In this study, we have demonstrated for the first time the efficacy of EPO in reducing sensorimotor and cognitive deficits, axonal and dendritic pathology, and the acute inflammatory response, concomitant to an increased expression of the endogenous EpoR in a combined rat model of diffuse brain injury and post-traumatic hypoxia. Here, EPO is linked to brain injury.